United States

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

12:08pm EDT
Change (% chg)

$-0.01 (-1.07%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for MEIP.OQ


MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the... (more)


Beta: 0.86
Market Cap(Mil.): $47.82
Shares Outstanding(Mil.): 34.16
Dividend: --
Yield (%): --


  MEIP.OQ Industry Sector
P/E (TTM): -- 41.28 37.71
EPS (TTM): -0.60 -- --
ROI: -37.11 -9.20 14.43
ROE: -37.11 -9.24 15.61

BRIEF-Mei PHARMA announces new clinical data for cancer drug

* Mei Pharma announces new clinical data from first-in-human study of ME-401, a next generation oral PI3K delta inhibitor

Apr 20 2016

BRIEF-MEI Pharma says amended company's restated by-laws

* Says amended and restated the company's amended and restated by-laws to add a new article XII

Mar 22 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : Pechala's Reports
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.